<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<!--<?xml-stylesheet type="text/xsl" href="article.xsl"?>-->
<article article-type="review-article" dtd-version="1.0" xml:lang="en"
    xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <front>
        <journal-meta>
            <journal-id journal-id-type="issn">0973-7510</journal-id>
            <journal-title-group>
                <journal-title>Journal of Pure and Applied Microbiology</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2581-690X</issn>
            <publisher>
                <publisher-name>DR. M.N. Khan</publisher-name>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.22207/JPAM.16.2.14</article-id>
            <title-group>
                <article-title>Acute Respiratory Distress Syndrome due to COVID-19 in India and efficacy of Indian Siddha drugs - A Trial of Lopinavir-Ritonavir</article-title>
            </title-group>
            <contrib-group>
				
				
				<contrib contrib-type="author">
                    <name>
                        <surname>Rajeshbabu</surname>
                        <given-names>P.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-1"/>
                </contrib>
				
						<contrib contrib-type="author">
                    <name>
                        <surname>Priadharsini</surname>
                        <given-names>K.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-2"/>
                </contrib>
				
				
				
				
				<contrib contrib-type="author">
                    <name>
                        <surname>Riyaz</surname>
                        <given-names>S.U. Mohammed</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-3"/>
                </contrib>
				
				
				
				<contrib contrib-type="author">
                    <name>
                        <surname>Dhayalan</surname>
                        <given-names>Manikandan</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff-4"/>
                </contrib>
				
				
								            		
            </contrib-group>
			
			
          <aff id="aff-1">Sai Biotech, Hosur, Tamil Nadu – 635 109, India.</aff>
			 <aff id="aff-2">Centre for Advanced Studies in Botany, University of Madras, Guindy Campus, Chennai – 600 025, India.</aff>
			  <aff id="aff-3">Molecular Biology Unit, PG and Research Department of Biotechnology, Islamiah College (Autonomous), Vaniyambadi, Tamil Nadu – 635752, India.</aff>
			   <aff id="aff-4">Anticancer Bioscience, Tianfu International Bio town, Chengdu 610000, China.</aff>
			 			
			
            <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2022-04-25">
                <day>25</day>
				<month>04</month>
                <year>2022</year>
            </pub-date>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>763</fpage>
            <lpage>768</lpage>
            <permissions>
                <copyright-statement>Copyright &#x00A9; 2022 The Author(s)</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license license-type="open-access"
                    xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.<uri 
					xlink:href="https://creativecommons.org/licenses/by/4.0/"
                            >https://creativecommons.org/licenses/by/4.0/</uri></license-p>
                </license>
            </permissions>
            <self-uri xlink:href="https://microbiologyjournal.org/acute-respiratory-distress-syndrome-due-to-covid-19-in-india-and-efficacy-of-indian-siddha-drugs-a-trial-of-lopinavir-ritonavir/"/>
            <abstract>
                <p> Novel coronavirus pneumonia (COVID-19) is a respiratory infection caused by infecting lungs and respiratory pathways which has rapidly spread to 216 countries. It is causing serious harm to the world’s entire population and a huge social burden, which can spread mainly by droplets produced during coughing and sneezing from animal to animal or human to human. There were no drugs or vaccines available as of May 2020. Though the severity and infectious behavior and mortality rate of COVID-19 led to the discovery of various vaccines and drugs that are available to control COVID-19 pandemic. India has two vaccines: Covishield and Covaxin approved by the Government of India on 2nd January 2021. Of this sudden and lethal disease, the traditional Indian siddha medicine was proficient as an alternative source, in performing differentiation with fewer side effects and better ability to prevent and control. In this article, we have comprehensively analyzed the case study and the efficacy of Indian Siddha medicine Kabasura Kudineer chooranam. Naturally occurring Indian Siddha medicinal (Kabasura Kudineer chooranam) compounds and its treatment as prevention measures so as to provide strategy and suggestions for the disease COVID-19 are discussed.</p>
		</abstract>
		<kwd-group>
        <title>Keywords</title>
        <kwd>COVID-19</kwd>
        <kwd>Kabasura Kudineer chooranam</kwd>
		<kwd>siddha drugs</kwd>
		
			</kwd-group>
        </article-meta>
    </front>
    </article>
